LINC01133 and neoplasm: In vitro assays with Hela, ME-180, C33A, and M5751 human tumor cell lines showed, through LINC01133 silencing, qRT-PCR, and phenotypic migration and invasion assays, that LINC01133 modulates EMT processes and increases cell invasion and migration capabilities.